Global Marek's Disease Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
LPI (LP Information)' newest research report, the “Marek's Disease Vaccine Industry Forecast” looks at past sales and reviews total world Marek's Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Marek's Disease Vaccine sales for 2023 through 2029. With Marek's Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Marek's Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Marek's Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Marek's Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Marek's Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Marek's Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Marek's Disease Vaccine.
The global Marek's Disease Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Marek's Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Marek's Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Marek's Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Marek's Disease Vaccine players cover Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Marek's Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Marek's Disease Vaccine market?
What factors are driving Marek's Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Marek's Disease Vaccine market opportunities vary by end market size?
How does Marek's Disease Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
LPI (LP Information)' newest research report, the “Marek's Disease Vaccine Industry Forecast” looks at past sales and reviews total world Marek's Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Marek's Disease Vaccine sales for 2023 through 2029. With Marek's Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Marek's Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Marek's Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Marek's Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Marek's Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Marek's Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Marek's Disease Vaccine.
The global Marek's Disease Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Marek's Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Marek's Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Marek's Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Marek's Disease Vaccine players cover Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Marek's Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Bivalent Vaccine
- Monovalent Vaccine
- Veterinary Pharmacy
- Online Sale
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Ceva
- Zoetis
- Boehringer Ingelheim
- Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
- Merial
- Ruipu Biopharmaceutical Co., Ltd.
- Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
- Beijing Huadu Shihua Biological Products Co., Ltd.
- Guangxi Lichengdong Biological Co., Ltd.
What is the 10-year outlook for the global Marek's Disease Vaccine market?
What factors are driving Marek's Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Marek's Disease Vaccine market opportunities vary by end market size?
How does Marek's Disease Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Marek's Disease Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Marek's Disease Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Marek's Disease Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Marek's Disease Vaccine Segment by Type
2.2.1 Bivalent Vaccine
2.2.2 Monovalent Vaccine
2.3 Marek's Disease Vaccine Sales by Type
2.3.1 Global Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Marek's Disease Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Marek's Disease Vaccine Sale Price by Type (2018-2023)
2.4 Marek's Disease Vaccine Segment by Application
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Marek's Disease Vaccine Sales by Application
2.5.1 Global Marek's Disease Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Marek's Disease Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Marek's Disease Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MAREK'S DISEASE VACCINE BY COMPANY
3.1 Global Marek's Disease Vaccine Breakdown Data by Company
3.1.1 Global Marek's Disease Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Marek's Disease Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Marek's Disease Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Marek's Disease Vaccine Revenue by Company (2018-2023)
3.2.2 Global Marek's Disease Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Marek's Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Marek's Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Marek's Disease Vaccine Product Location Distribution
3.4.2 Players Marek's Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MAREK'S DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Marek's Disease Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Marek's Disease Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Marek's Disease Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Marek's Disease Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Marek's Disease Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Marek's Disease Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Marek's Disease Vaccine Sales Growth
4.4 APAC Marek's Disease Vaccine Sales Growth
4.5 Europe Marek's Disease Vaccine Sales Growth
4.6 Middle East & Africa Marek's Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Marek's Disease Vaccine Sales by Country
5.1.1 Americas Marek's Disease Vaccine Sales by Country (2018-2023)
5.1.2 Americas Marek's Disease Vaccine Revenue by Country (2018-2023)
5.2 Americas Marek's Disease Vaccine Sales by Type
5.3 Americas Marek's Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Marek's Disease Vaccine Sales by Region
6.1.1 APAC Marek's Disease Vaccine Sales by Region (2018-2023)
6.1.2 APAC Marek's Disease Vaccine Revenue by Region (2018-2023)
6.2 APAC Marek's Disease Vaccine Sales by Type
6.3 APAC Marek's Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Marek's Disease Vaccine by Country
7.1.1 Europe Marek's Disease Vaccine Sales by Country (2018-2023)
7.1.2 Europe Marek's Disease Vaccine Revenue by Country (2018-2023)
7.2 Europe Marek's Disease Vaccine Sales by Type
7.3 Europe Marek's Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Marek's Disease Vaccine by Country
8.1.1 Middle East & Africa Marek's Disease Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Marek's Disease Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Marek's Disease Vaccine Sales by Type
8.3 Middle East & Africa Marek's Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Marek's Disease Vaccine
10.3 Manufacturing Process Analysis of Marek's Disease Vaccine
10.4 Industry Chain Structure of Marek's Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Marek's Disease Vaccine Distributors
11.3 Marek's Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR MAREK'S DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Marek's Disease Vaccine Market Size Forecast by Region
12.1.1 Global Marek's Disease Vaccine Forecast by Region (2024-2029)
12.1.2 Global Marek's Disease Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Marek's Disease Vaccine Forecast by Type
12.7 Global Marek's Disease Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Marek's Disease Vaccine Product Portfolios and Specifications
13.1.3 Merck Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Ceva
13.2.1 Ceva Company Information
13.2.2 Ceva Marek's Disease Vaccine Product Portfolios and Specifications
13.2.3 Ceva Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ceva Main Business Overview
13.2.5 Ceva Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Marek's Disease Vaccine Product Portfolios and Specifications
13.3.3 Zoetis Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
13.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
13.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Main Business Overview
13.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Latest Developments
13.6 Merial
13.6.1 Merial Company Information
13.6.2 Merial Marek's Disease Vaccine Product Portfolios and Specifications
13.6.3 Merial Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merial Main Business Overview
13.6.5 Merial Latest Developments
13.7 Ruipu Biopharmaceutical Co., Ltd.
13.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
13.7.2 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview
13.7.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments
13.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
13.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
13.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview
13.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
13.9 Beijing Huadu Shihua Biological Products Co., Ltd.
13.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
13.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Main Business Overview
13.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Latest Developments
13.10 Guangxi Lichengdong Biological Co., Ltd.
13.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
13.10.2 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Guangxi Lichengdong Biological Co., Ltd. Main Business Overview
13.10.5 Guangxi Lichengdong Biological Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Marek's Disease Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Marek's Disease Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Marek's Disease Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Marek's Disease Vaccine Segment by Type
2.2.1 Bivalent Vaccine
2.2.2 Monovalent Vaccine
2.3 Marek's Disease Vaccine Sales by Type
2.3.1 Global Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Marek's Disease Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Marek's Disease Vaccine Sale Price by Type (2018-2023)
2.4 Marek's Disease Vaccine Segment by Application
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Marek's Disease Vaccine Sales by Application
2.5.1 Global Marek's Disease Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Marek's Disease Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Marek's Disease Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MAREK'S DISEASE VACCINE BY COMPANY
3.1 Global Marek's Disease Vaccine Breakdown Data by Company
3.1.1 Global Marek's Disease Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Marek's Disease Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Marek's Disease Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Marek's Disease Vaccine Revenue by Company (2018-2023)
3.2.2 Global Marek's Disease Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Marek's Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Marek's Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Marek's Disease Vaccine Product Location Distribution
3.4.2 Players Marek's Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MAREK'S DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Marek's Disease Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Marek's Disease Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Marek's Disease Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Marek's Disease Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Marek's Disease Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Marek's Disease Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Marek's Disease Vaccine Sales Growth
4.4 APAC Marek's Disease Vaccine Sales Growth
4.5 Europe Marek's Disease Vaccine Sales Growth
4.6 Middle East & Africa Marek's Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Marek's Disease Vaccine Sales by Country
5.1.1 Americas Marek's Disease Vaccine Sales by Country (2018-2023)
5.1.2 Americas Marek's Disease Vaccine Revenue by Country (2018-2023)
5.2 Americas Marek's Disease Vaccine Sales by Type
5.3 Americas Marek's Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Marek's Disease Vaccine Sales by Region
6.1.1 APAC Marek's Disease Vaccine Sales by Region (2018-2023)
6.1.2 APAC Marek's Disease Vaccine Revenue by Region (2018-2023)
6.2 APAC Marek's Disease Vaccine Sales by Type
6.3 APAC Marek's Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Marek's Disease Vaccine by Country
7.1.1 Europe Marek's Disease Vaccine Sales by Country (2018-2023)
7.1.2 Europe Marek's Disease Vaccine Revenue by Country (2018-2023)
7.2 Europe Marek's Disease Vaccine Sales by Type
7.3 Europe Marek's Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Marek's Disease Vaccine by Country
8.1.1 Middle East & Africa Marek's Disease Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Marek's Disease Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Marek's Disease Vaccine Sales by Type
8.3 Middle East & Africa Marek's Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Marek's Disease Vaccine
10.3 Manufacturing Process Analysis of Marek's Disease Vaccine
10.4 Industry Chain Structure of Marek's Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Marek's Disease Vaccine Distributors
11.3 Marek's Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR MAREK'S DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Marek's Disease Vaccine Market Size Forecast by Region
12.1.1 Global Marek's Disease Vaccine Forecast by Region (2024-2029)
12.1.2 Global Marek's Disease Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Marek's Disease Vaccine Forecast by Type
12.7 Global Marek's Disease Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Marek's Disease Vaccine Product Portfolios and Specifications
13.1.3 Merck Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Ceva
13.2.1 Ceva Company Information
13.2.2 Ceva Marek's Disease Vaccine Product Portfolios and Specifications
13.2.3 Ceva Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ceva Main Business Overview
13.2.5 Ceva Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Marek's Disease Vaccine Product Portfolios and Specifications
13.3.3 Zoetis Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
13.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
13.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Main Business Overview
13.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Latest Developments
13.6 Merial
13.6.1 Merial Company Information
13.6.2 Merial Marek's Disease Vaccine Product Portfolios and Specifications
13.6.3 Merial Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merial Main Business Overview
13.6.5 Merial Latest Developments
13.7 Ruipu Biopharmaceutical Co., Ltd.
13.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
13.7.2 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview
13.7.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments
13.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
13.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
13.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview
13.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
13.9 Beijing Huadu Shihua Biological Products Co., Ltd.
13.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
13.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Main Business Overview
13.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Latest Developments
13.10 Guangxi Lichengdong Biological Co., Ltd.
13.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
13.10.2 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
13.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Guangxi Lichengdong Biological Co., Ltd. Main Business Overview
13.10.5 Guangxi Lichengdong Biological Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Marek's Disease Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Marek's Disease Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Bivalent Vaccine
Table 4. Major Players of Monovalent Vaccine
Table 5. Global Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Marek's Disease Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Marek's Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Marek's Disease Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Marek's Disease Vaccine Revenue by Application (2018-2023)
Table 13. Global Marek's Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Marek's Disease Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Marek's Disease Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Marek's Disease Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Marek's Disease Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Marek's Disease Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Marek's Disease Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Marek's Disease Vaccine Producing Area Distribution and Sales Area
Table 21. Players Marek's Disease Vaccine Products Offered
Table 22. Marek's Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Marek's Disease Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Marek's Disease Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Marek's Disease Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Marek's Disease Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Marek's Disease Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Marek's Disease Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Marek's Disease Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Marek's Disease Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Marek's Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Marek's Disease Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Marek's Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Marek's Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Marek's Disease Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Marek's Disease Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Marek's Disease Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Marek's Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Marek's Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Marek's Disease Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Marek's Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Marek's Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Marek's Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Marek's Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Marek's Disease Vaccine
Table 58. Key Market Challenges & Risks of Marek's Disease Vaccine
Table 59. Key Industry Trends of Marek's Disease Vaccine
Table 60. Marek's Disease Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Marek's Disease Vaccine Distributors List
Table 63. Marek's Disease Vaccine Customer List
Table 64. Global Marek's Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Marek's Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Marek's Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Marek's Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Marek's Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Marek's Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Marek's Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Marek's Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Marek's Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Marek's Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Marek's Disease Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Marek's Disease Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Marek's Disease Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Marek's Disease Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Marek's Disease Vaccine Product Portfolios and Specifications
Table 80. Merck Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Ceva Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Ceva Marek's Disease Vaccine Product Portfolios and Specifications
Table 85. Ceva Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Ceva Main Business
Table 87. Ceva Latest Developments
Table 88. Zoetis Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Marek's Disease Vaccine Product Portfolios and Specifications
Table 90. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Boehringer Ingelheim Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer Ingelheim Marek's Disease Vaccine Product Portfolios and Specifications
Table 95. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boehringer Ingelheim Main Business
Table 97. Boehringer Ingelheim Latest Developments
Table 98. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 100. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Main Business
Table 102. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Latest Developments
Table 103. Merial Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merial Marek's Disease Vaccine Product Portfolios and Specifications
Table 105. Merial Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Merial Main Business
Table 107. Merial Latest Developments
Table 108. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 110. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Ruipu Biopharmaceutical Co., Ltd. Main Business
Table 112. Ruipu Biopharmaceutical Co., Ltd. Latest Developments
Table 113. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 115. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business
Table 117. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
Table 118. Beijing Huadu Shihua Biological Products Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 120. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Beijing Huadu Shihua Biological Products Co., Ltd. Main Business
Table 122. Beijing Huadu Shihua Biological Products Co., Ltd. Latest Developments
Table 123. Guangxi Lichengdong Biological Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 125. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Guangxi Lichengdong Biological Co., Ltd. Main Business
Table 127. Guangxi Lichengdong Biological Co., Ltd. Latest Developments
Table 1. Marek's Disease Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Marek's Disease Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Bivalent Vaccine
Table 4. Major Players of Monovalent Vaccine
Table 5. Global Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Marek's Disease Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Marek's Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Marek's Disease Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Marek's Disease Vaccine Revenue by Application (2018-2023)
Table 13. Global Marek's Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Marek's Disease Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Marek's Disease Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Marek's Disease Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Marek's Disease Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Marek's Disease Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Marek's Disease Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Marek's Disease Vaccine Producing Area Distribution and Sales Area
Table 21. Players Marek's Disease Vaccine Products Offered
Table 22. Marek's Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Marek's Disease Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Marek's Disease Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Marek's Disease Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Marek's Disease Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Marek's Disease Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Marek's Disease Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Marek's Disease Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Marek's Disease Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Marek's Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Marek's Disease Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Marek's Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Marek's Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Marek's Disease Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Marek's Disease Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Marek's Disease Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Marek's Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Marek's Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Marek's Disease Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Marek's Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Marek's Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Marek's Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Marek's Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Marek's Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Marek's Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Marek's Disease Vaccine
Table 58. Key Market Challenges & Risks of Marek's Disease Vaccine
Table 59. Key Industry Trends of Marek's Disease Vaccine
Table 60. Marek's Disease Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Marek's Disease Vaccine Distributors List
Table 63. Marek's Disease Vaccine Customer List
Table 64. Global Marek's Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Marek's Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Marek's Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Marek's Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Marek's Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Marek's Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Marek's Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Marek's Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Marek's Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Marek's Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Marek's Disease Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Marek's Disease Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Marek's Disease Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Marek's Disease Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Marek's Disease Vaccine Product Portfolios and Specifications
Table 80. Merck Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Ceva Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Ceva Marek's Disease Vaccine Product Portfolios and Specifications
Table 85. Ceva Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Ceva Main Business
Table 87. Ceva Latest Developments
Table 88. Zoetis Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Marek's Disease Vaccine Product Portfolios and Specifications
Table 90. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Boehringer Ingelheim Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer Ingelheim Marek's Disease Vaccine Product Portfolios and Specifications
Table 95. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boehringer Ingelheim Main Business
Table 97. Boehringer Ingelheim Latest Developments
Table 98. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 100. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Main Business
Table 102. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Latest Developments
Table 103. Merial Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merial Marek's Disease Vaccine Product Portfolios and Specifications
Table 105. Merial Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Merial Main Business
Table 107. Merial Latest Developments
Table 108. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 110. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Ruipu Biopharmaceutical Co., Ltd. Main Business
Table 112. Ruipu Biopharmaceutical Co., Ltd. Latest Developments
Table 113. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 115. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business
Table 117. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
Table 118. Beijing Huadu Shihua Biological Products Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 120. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Beijing Huadu Shihua Biological Products Co., Ltd. Main Business
Table 122. Beijing Huadu Shihua Biological Products Co., Ltd. Latest Developments
Table 123. Guangxi Lichengdong Biological Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolios and Specifications
Table 125. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Guangxi Lichengdong Biological Co., Ltd. Main Business
Table 127. Guangxi Lichengdong Biological Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Marek's Disease Vaccine
Figure 2. Marek's Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Marek's Disease Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Marek's Disease Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Marek's Disease Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Bivalent Vaccine
Figure 10. Product Picture of Monovalent Vaccine
Figure 11. Global Marek's Disease Vaccine Sales Market Share by Type in 2022
Figure 12. Global Marek's Disease Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Marek's Disease Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Marek's Disease Vaccine Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 15. Marek's Disease Vaccine Consumed in Online Sale
Figure 16. Global Marek's Disease Vaccine Market: Online Sale (2018-2023) & (K Units)
Figure 17. Marek's Disease Vaccine Consumed in Others
Figure 18. Global Marek's Disease Vaccine Market: Others (2018-2023) & (K Units)
Figure 19. Global Marek's Disease Vaccine Sales Market Share by Application (2022)
Figure 20. Global Marek's Disease Vaccine Revenue Market Share by Application in 2022
Figure 21. Marek's Disease Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Marek's Disease Vaccine Sales Market Share by Company in 2022
Figure 23. Marek's Disease Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Marek's Disease Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Marek's Disease Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Marek's Disease Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Marek's Disease Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Marek's Disease Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Marek's Disease Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Marek's Disease Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Marek's Disease Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Marek's Disease Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Marek's Disease Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Marek's Disease Vaccine
Figure 74. Industry Chain Structure of Marek's Disease Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Marek's Disease Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Marek's Disease Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Marek's Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Marek's Disease Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Marek's Disease Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Marek's Disease Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Marek's Disease Vaccine
Figure 2. Marek's Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Marek's Disease Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Marek's Disease Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Marek's Disease Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Bivalent Vaccine
Figure 10. Product Picture of Monovalent Vaccine
Figure 11. Global Marek's Disease Vaccine Sales Market Share by Type in 2022
Figure 12. Global Marek's Disease Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Marek's Disease Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Marek's Disease Vaccine Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 15. Marek's Disease Vaccine Consumed in Online Sale
Figure 16. Global Marek's Disease Vaccine Market: Online Sale (2018-2023) & (K Units)
Figure 17. Marek's Disease Vaccine Consumed in Others
Figure 18. Global Marek's Disease Vaccine Market: Others (2018-2023) & (K Units)
Figure 19. Global Marek's Disease Vaccine Sales Market Share by Application (2022)
Figure 20. Global Marek's Disease Vaccine Revenue Market Share by Application in 2022
Figure 21. Marek's Disease Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Marek's Disease Vaccine Sales Market Share by Company in 2022
Figure 23. Marek's Disease Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Marek's Disease Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Marek's Disease Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Marek's Disease Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Marek's Disease Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Marek's Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Marek's Disease Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Marek's Disease Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Marek's Disease Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Marek's Disease Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Marek's Disease Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Marek's Disease Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Marek's Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Marek's Disease Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Marek's Disease Vaccine
Figure 74. Industry Chain Structure of Marek's Disease Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Marek's Disease Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Marek's Disease Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Marek's Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Marek's Disease Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Marek's Disease Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Marek's Disease Vaccine Revenue Market Share Forecast by Application (2024-2029)
